Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension.

Ulrich A, Wharton J, Thayer TE, Swietlik EM, Assad TR, Desai AA, Gräf S, Harbaum L, Humbert M, Morrell NW, Nichols WC, Soubrier F, Southgate L, Trégouët DA, Trembath RC, Brittain EL, Wilkins MR, Prokopenko I, Rhodes CJ; NIHR BioResource – Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Eur Respir J. 2019 Nov 19. pii: 1901486. doi: 10.1183/13993003.01486-2019. [Epub ahead of print]

PMID:
31744833
2.

Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis.

Zhao J, Mo H, Guo X, Wang Q, Xu D, Hou Y, Tian Z, Liu Y, Wang H, Lai J, Li M, Zeng X.

Clin Rheumatol. 2018 Apr;37(4):979-985. doi: 10.1007/s10067-017-3918-9. Epub 2017 Nov 21.

PMID:
29164429
3.

Usefulness of Red Cell Width Distribution (RDW) in the Assessment of Children with Pulmonary Arterial Hypertension (PAH).

Zuk M, Migdal A, Dominczak J, Brzezinska-Rajszys G.

Pediatr Cardiol. 2019 Apr;40(4):820-826. doi: 10.1007/s00246-019-02077-4. Epub 2019 Mar 4.

4.

Red Blood Cells Distribution Width as a Potential Prognostic Biomarker in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.

Smukowska-Gorynia A, Tomaszewska I, Malaczynska-Rajpold K, Marcinkowska J, Komosa A, Janus M, Olasinska-Wisniewska A, Slawek S, Araszkiewicz A, Jankiewicz S, Mularek-Kubzdela T.

Heart Lung Circ. 2018 Jul;27(7):842-848. doi: 10.1016/j.hlc.2017.08.007. Epub 2017 Aug 24.

PMID:
29107511
5.

Unbiased Phenome-Wide Association Studies of Red Cell Distribution Width Identifies Key Associations with Pulmonary Hypertension.

Thayer TE, Huang S, Levinson RT, Farber-Eger E, Assad TR, Huston JH, Mosley JD, Wells QS, Brittain EL.

Ann Am Thorac Soc. 2019 May;16(5):589-598. doi: 10.1513/AnnalsATS.201809-594OC.

PMID:
30608875
6.

Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren's syndrome: a retrospective cohort study.

Hui M, Zhao J, Tian Z, Wang J, Qian J, Yang X, Wang Q, Li M, Zhao Y, Zeng X.

Clin Rheumatol. 2019 Feb;38(2):477-485. doi: 10.1007/s10067-018-4281-1. Epub 2018 Sep 14.

PMID:
30218288
7.

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders.

Bellan M, Giubertoni A, Piccinino C, Dimagli A, Grimoldi F, Sguazzotti M, Burlone ME, Smirne C, Sola D, Marino P, Pirisi M, Sainaghi PP.

Dis Markers. 2019 Jun 2;2019:4981982. doi: 10.1155/2019/4981982. eCollection 2019.

8.

Baseline Red Blood Cell Distribution Width Correlates with Disease Activity and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus, Irrespective of Anemia Status.

Zou XL, Lin XJ, Ni X, Wang J, Liu W, Wei J.

Clin Lab. 2016 Oct 1;62(10):1841-1850. doi: 10.7754/Clin.Lab.2016.160213.

PMID:
28164513
9.

Phosphodiesterase 5 inhibitors for pulmonary hypertension.

Barnes H, Brown Z, Burns A, Williams T.

Cochrane Database Syst Rev. 2019 Jan 31;1:CD012621. doi: 10.1002/14651858.CD012621.pub2.

PMID:
30701543
10.

High levels of zinc-protoporphyrin identify iron metabolic abnormalities in pulmonary arterial hypertension.

Decker I, Ghosh S, Comhair SA, Farha S, Tang WH, Park M, Wang S, Lichtin AE, Erzurum SC.

Clin Transl Sci. 2011 Aug;4(4):253-8. doi: 10.1111/j.1752-8062.2011.00301.x.

11.

Red Blood Cell Distribution Width in Patients With Chronic Obstructive Pulmonary Disease and Healthy Subjects.

Ozgul G, Seyhan EC, Özgül MA, Günlüoğlu MZ.

Arch Bronconeumol. 2017 Mar;53(3):107-113. doi: 10.1016/j.arbres.2016.05.021. Epub 2016 Sep 23. English, Spanish.

12.

The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study.

Van Craenenbroeck EM, Conraads VM, Greenlaw N, Gaudesius G, Mori C, Ponikowski P, Anker SD.

Eur J Heart Fail. 2013 Jul;15(7):756-62. doi: 10.1093/eurjhf/hft068. Epub 2013 May 2.

13.

Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease.

Seyhan EC, Özgül MA, Tutar N, Ömür I, Uysal A, Altin S.

COPD. 2013 Aug;10(4):416-24. doi: 10.3109/15412555.2012.758697. Epub 2013 Mar 28.

PMID:
23537076
14.

Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.

Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR.

Heart. 2011 Jul;97(13):1054-60. doi: 10.1136/hrt.2011.224857. Epub 2011 May 10.

PMID:
21558476
15.

Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure.

Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, Mendonca M, Rashid M, Kang S, Weissert S, Coats CJ, Richards T, Thomas M, Woldman S, Okonko DO.

Int J Cardiol. 2013 Oct 3;168(3):1997-2002. doi: 10.1016/j.ijcard.2012.12.091. Epub 2013 Jan 22.

PMID:
23351789
16.

Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Abul Y, Ozsu S, Korkmaz A, Bulbul Y, Orem A, Ozlu T.

Chron Respir Dis. 2014 May;11(2):73-81. doi: 10.1177/1479972314525057. Epub 2014 Mar 4.

PMID:
24595892
17.

Red cell distribution width as a measure of severity of iron deficiency in iron deficiency anaemia.

Das Gupta A, Hegde C, Mistri R.

Indian J Med Res. 1994 Oct;100:177-83.

PMID:
7851969
18.

Value of red cell distribution width (RDW) and RBC indices in the detection of iron deficiency anemia.

Sultana GS, Haque SA, Sultana T, Ahmed AN.

Mymensingh Med J. 2013 Apr;22(2):370-6.

PMID:
23715364
19.

Role of red cell distribution width in classifying microcytic hypochromic anaemia.

Buch AC, Karve PP, Panicker NK, Singru SA, Gupta SC.

J Indian Med Assoc. 2011 May;109(5):297-9.

PMID:
22187759
20.

Pulmonary Arterial Hypertension: Screening, Management, and Treatment [Internet].

McCrory DC, Coeytaux RR, Schmit KM, Kraft B, Kosinski AS, Mingo AM, Vann LM, Gilstrap DL, Hargett CW, Lugogo NL, Heidenfelder BL, Posey R, Irvine RJ, Wing L, Pendergast K, Dolor RJ.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr.

Supplemental Content

Support Center